Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betaferon for induction of interferon-beta tolerance in multiple sclerosis patients with neutralising antibodies to Rebif
2005-005751-18Phase 2Terminated
- Sponsor
- UCL Biomedicine R&D Unit
- Start
- Feb 2006
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of interferon beta-1a in multiple sclerosis (MS), sponsored by UCL Biomedicine R&D Unit. Started Feb 2006; status: terminated.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2005-005751-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005751-18.